I think I remember complaining more than a year ago that I just looked at about 3 dozen small biotechs that ALL had way less of a pipeline than MRKR, ALL were either in "PRE-clincal" or JUST started Phase 1, and ALL had a market cap of 5 times to 20 times what MRKR was at.
It was crazy to me then and it is still crazy to me now. I just hope our day will come and we will shoot up 1000% or 2000% on some great data.